Why Cannabis Cultivators Cannot Access Traditional Bank Financing
The fundamental challenge for cannabis grow facility operators seeking financing is the federal illegality of cannabis under the Controlled Substances Act. Because cannabis remains a Schedule I substance at the federal level, national banks and credit unions regulated by the FDIC, OCC, and NCUA face severe legal and regulatory risk if they lend to plant-touching businesses. While the SAFE Banking Act and similar legislative efforts have been introduced repeatedly in Congress, none have become law as of early 2026, leaving the cannabis industry largely locked out of the traditional banking and lending infrastructure that other industries take for granted.
This exclusion from conventional lending has real financial consequences for cultivators. A non-cannabis agricultural business expanding its facilities might secure an SBA 504 loan at 6% to 8% interest with a 25-year amortization and 10% to 15% down. A cannabis cultivator seeking the same expansion must turn to private capital markets where rates start at 12% and often exceed 20%, terms are shorter, and equity participation or warrants may be required. The interest rate premium that cannabis operators pay -- often 5 to 15 percentage points above conventional rates -- represents one of the most significant structural disadvantages the industry faces.
Understanding the lending landscape, knowing which type of lender fits your situation, and presenting your business in the strongest possible light are the three levers cultivators can pull to minimize that premium and maximize their chances of securing capital on favorable terms.
What Types of Lenders Serve Cannabis Grow Facilities?
The cannabis lending ecosystem has matured significantly since the early legalization years. Today, cultivators have access to several distinct categories of capital, each with different structures, costs, and requirements.
Private Credit Funds and Cannabis-Specific Lenders
Private credit funds are the most active lenders in the cannabis cultivation space. These are institutional or semi-institutional investment vehicles that raise capital from accredited investors, family offices, and fund-of-funds specifically to deploy into cannabis lending. Firms in this category include operations like Pelorus Equity Group, Bespoke Financial, and AFC Gamma (now part of Chicago Atlantic), among others.
Private credit loans to cannabis cultivators typically range from $1 million to $50 million, with interest rates between 12% and 24% depending on the borrower's credit profile, collateral package, and market conditions. Loan terms are generally 1 to 5 years, often with interest-only periods during the first 6 to 18 months followed by amortization. Many private credit lenders require personal guarantees from the business owners, and some negotiate for equity kickers -- warrants or conversion rights that give the lender upside participation if the business performs well.
The advantage of private credit is speed and flexibility. These lenders understand the cannabis industry, can structure non-standard deals, and typically close in 30 to 90 days once underwriting begins. The disadvantage is cost -- the all-in cost of capital including origination fees (typically 1% to 3% of the loan amount), interest, and any equity participation can be 15% to 28% annualized.
Sale-Leaseback Arrangements
Sale-leaseback financing has become one of the most popular structures for cannabis cultivators who own their real estate. In a sale-leaseback, the cultivator sells its property to a real estate investor or REIT and simultaneously signs a long-term lease (typically 10 to 20 years with renewal options) to continue operating in the facility. The cultivator receives cash from the property sale and converts its ownership equity into a lease obligation.
The effective cost of capital in a sale-leaseback depends on the cap rate at which the property is sold, which in cannabis real estate typically ranges from 8% to 14%. A cultivator who sells a facility valued at $5 million at a 10% cap rate receives $5 million in cash and takes on an annual lease obligation of $500,000. Compared to private credit, sale-leasebacks often provide a lower effective cost of capital because the lender's risk is secured by real property that retains value regardless of the cannabis business's performance.
Cannabis-focused REITs like Innovative Industrial Properties (IIPR), which has acquired over $2.5 billion in cannabis real estate, have been significant players in this space. However, cultivators should carefully evaluate the lease terms, particularly annual rent escalators (typically 2% to 3.5% per year), triple-net obligations that shift property taxes, insurance, and maintenance to the tenant, and restrictions on subleasing or facility modifications.
Equipment Financing and Leasing
Equipment financing allows cultivators to fund specific capital expenditures -- lighting systems, HVAC, irrigation, extraction equipment, trimming machines -- without pledging real estate or taking on general-purpose debt. Equipment loans and leases are secured by the equipment itself, which reduces lender risk and typically results in lower interest rates than unsecured private credit.
Interest rates for cannabis equipment financing generally range from 8% to 15%, with terms of 3 to 7 years matching the useful life of the financed assets. Some equipment financing companies specialize in the cannabis industry and have standardized programs for common cultivation equipment packages, which streamlines the approval process.
The typical equipment financing structure covers 70% to 90% of the equipment purchase price, with the cultivator providing the remaining 10% to 30% as a down payment. For a $500,000 lighting and HVAC upgrade, a cultivator might finance $400,000 at 11% over 5 years, resulting in monthly payments of approximately $8,700. The equipment serves as collateral, and if the borrower defaults, the lender repossesses the equipment -- a cleaner recovery process than foreclosing on a cannabis-licensed property.
Hard Money and Bridge Loans
Hard money loans serve cultivators who need capital quickly and cannot qualify for the more structured lending options described above. These loans are secured primarily by real estate collateral and funded by individual investors or small lending companies. Interest rates are the highest in the market -- 18% to 30% -- and terms are the shortest, typically 6 to 24 months. Points (upfront fees) of 2% to 5% are standard.
Hard money financing is appropriate as a bridge -- funding a time-sensitive acquisition, covering a gap between construction completion and permanent financing, or providing working capital during a seasonal cash flow crunch. It should never be used as long-term financing because the cost of capital will erode profitability to the point where the business becomes unsustainable.
What Do Cannabis Grow Facility Lenders Require to Approve a Loan?
Regardless of the lender type, cannabis cultivation lenders evaluate borrowers against a consistent set of criteria. Understanding these criteria before beginning the application process allows cultivators to prepare materials that address lender concerns proactively.
Licensing and Regulatory Standing
Every cannabis lender's first question is whether the borrower holds valid state and local licenses to operate. Lenders will verify that all licenses are current, that there are no pending enforcement actions or compliance violations, and that the license is transferable or can be pledged as part of the collateral package. A cultivation operation with a clean compliance record is significantly more attractive to lenders than one with a history of regulatory infractions, even if the financial metrics are similar.
Financial Performance and Operating History
Most cannabis lenders require a minimum of 12 months of operating history, and many prefer 24 months or more. Startups and pre-revenue operations face extremely limited lending options -- most capital for early-stage cultivators comes from equity investors rather than debt providers.
Lenders want to see financial statements that demonstrate consistent revenue, stable or improving gross margins, and sufficient cash flow to service the proposed debt. The key metric is the debt-service coverage ratio (DSCR) -- the ratio of net operating income (or adjusted EBITDA) to total annual debt payments. Most cannabis lenders require a DSCR of 1.25x or better, meaning the business generates at least $1.25 in cash flow for every $1.00 in debt service. A DSCR below 1.0x means the business cannot cover its debt payments from operations, which is a disqualifier for virtually all lenders.
Financial statements should be prepared on an accrual basis and reviewed or compiled by a CPA, ideally one with cannabis industry expertise. Tax returns for the most recent two years should be consistent with the financial statements. Significant discrepancies between financial statements and tax returns -- which are common in cannabis businesses due to 280E adjustments -- must be clearly explained in a reconciliation schedule.
Collateral and Loan-to-Value Requirements
Cannabis loans are almost always secured by collateral, and the type and value of collateral directly affects the loan terms. Real estate is the most valued collateral, and lenders typically require a loan-to-value (LTV) ratio of 50% to 75%, meaning the loan amount can be no more than 50% to 75% of the appraised property value. Equipment collateral is discounted more heavily -- lenders may advance only 40% to 60% of equipment value because cannabis-specific equipment has a limited resale market.
Personal guarantees from the business owners are required by most cannabis lenders. Some lenders will also require a UCC filing on all business assets, assignment of license proceeds (to the extent permitted by state law), and key-person life insurance on the primary operators.
Use of Proceeds and Growth Plan
Lenders do not just want to know how much you need -- they want to know exactly what you will do with the money and how it will increase the business's ability to repay the loan. A clear use-of-proceeds plan should specify the amount allocated to each expenditure category (construction, equipment, working capital), the timeline for deployment, the expected impact on production capacity and revenue, and a detailed projection showing how the increased cash flow will service the additional debt.
A cultivator seeking $2 million to add 5,000 square feet of canopy should be able to demonstrate that the expansion will produce an incremental X pounds per year at an average wholesale price of $Y per pound, generating $Z in additional annual revenue with a gross margin of W%, resulting in incremental EBITDA that covers debt service at a DSCR of 1.5x or better. The more specific and data-driven the projections, the more confidence the lender has in the borrower's ability to execute.
How Should Cannabis Cultivators Prepare Financially for a Loan Application?
The financial preparation process should begin 3 to 6 months before submitting a loan application. This lead time allows the business to clean up its financial records, resolve any accounting issues, and present the strongest possible case to lenders.
Step one is getting the books audit-ready. This means ensuring that the general ledger is complete and accurate, that all bank accounts are reconciled through the most recent month, that accounts receivable and accounts payable are current, and that inventory records match physical counts and seed-to-sale system data. Lenders will scrutinize the financials, and any errors, gaps, or inconsistencies will delay the process or result in a denial.
Step two is preparing a 280E-adjusted cash flow analysis. Because Section 280E inflates the effective tax rate for cannabis businesses, standard financial projections can dramatically overstate available cash flow. A lender-ready projection must account for the actual federal tax liability after 280E is applied, which often results in effective tax rates of 50% to 70% for profitable cannabis operations. Presenting unadjusted projections that ignore 280E signals to the lender that the borrower does not understand its own economics.
Step three is assembling a professional loan package. This package should include an executive summary of the business and the financing request, two years of historical financial statements (CPA-prepared), two years of federal and state tax returns, a detailed financial projection for the loan term, the 280E-adjusted cash flow analysis, a use-of-proceeds schedule, property appraisals or equipment valuations as applicable, copies of all licenses and permits, and personal financial statements and tax returns for all guarantors.
Step four is engaging professional advisors. A cannabis CPA or fractional CFO who has experience with cannabis lending transactions can prepare financial statements in the format lenders expect, identify and address issues that would cause lender concerns before they arise, build projections that reflect realistic industry benchmarks, and make introductions to lenders who are actively deploying capital in the cannabis cultivation space. At Northstar, we have facilitated cannabis lending transactions ranging from $500,000 equipment loans to $15 million sale-leaseback transactions, and in every case, the financial preparation we provided was cited by the lender as a factor that expedited the approval process.
What Interest Rates and Loan Terms Can Cannabis Cultivators Expect?
As a benchmark for planning purposes, cannabis cultivators should expect the following ranges as of 2026. Private credit and term loans carry interest rates of 12% to 24%, with terms of 1 to 5 years and LTV ratios of 50% to 70%. Sale-leaseback arrangements effectively cost 8% to 14% (expressed as cap rates), with lease terms of 10 to 20 years. Equipment financing falls in the 8% to 15% range, with terms of 3 to 7 years and advance rates of 70% to 90% of equipment cost. Hard money and bridge loans range from 18% to 30%, with terms of 6 to 24 months and LTV ratios of 40% to 65%.
These ranges are influenced by several factors specific to the borrower, including the state in which the cultivation operation is located (mature markets like Colorado and Oregon generally offer better terms than emerging markets), the scale of the operation, the borrower's personal credit score and net worth, the quality of the collateral package, and the overall health of the cannabis capital markets at the time of application.
How Will Federal Legalization or Rescheduling Affect Cannabis Lending?
The prospect of federal rescheduling (moving cannabis from Schedule I to Schedule III, as recommended by the Department of Health and Human Services in 2023) or full legalization would fundamentally reshape the cannabis lending landscape. If cannabis were rescheduled to Schedule III, Section 280E would no longer apply, which would dramatically improve cannabis businesses' after-tax cash flows and make them more attractive to lenders. The elimination of 280E alone could reduce effective tax rates from 50% to 70% down to 25% to 35%, roughly doubling the free cash flow available for debt service.
More importantly, rescheduling or legalization would open the door for traditional banks and credit unions to lend to cannabis businesses. The influx of conventional capital would compress interest rates toward the levels that other regulated industries pay. Cannabis cultivators might eventually access SBA loans, conventional commercial mortgages, and standard equipment financing at rates of 6% to 10% -- a dramatic reduction from current levels.
However, the timeline for these changes remains uncertain, and cultivators should not defer financing decisions based on speculation about legislative outcomes. The cultivation operations that are building strong financial foundations today -- clean books, professional financial reporting, and solid lender relationships -- will be best positioned to take advantage of more favorable terms when they eventually become available.
How Northstar Helps Cannabis Cultivators Secure Financing
At Northstar Financial, we serve as fractional CFO and financial advisor to cannabis cultivation operations navigating the lending process. Our role includes preparing audit-ready financial statements and 280E-adjusted projections, assembling professional loan packages that meet lender documentation requirements, modeling different financing structures to identify the lowest total cost of capital, making introductions to active cannabis lenders in our network, and providing ongoing financial oversight after the loan closes to ensure covenant compliance and performance tracking. The difference between a well-prepared loan application and a poorly prepared one is not marginal -- it often determines whether the application is approved, how quickly it closes, and what terms the lender offers.